Department of Medicine
Faculty Profiles by Division

Department of Medicine

Faculty Profiles

[Return To Index page]
photo Carolyn J Anderson, PhD

Cardiology

Professor of Medicine

Email: andersoncj@upmc.edu

Phone: 412-624-6887

Contact
Office: Biomedical Science Tower 3
3501 Fifth Ave
Pittsburgh, PA 15260
 
Phone: 412-624-6887
Fax:
E-mail: andersoncj@upmc.edu
Administrative Assistant:
Amanda Bisesi
Email: bisesia@upmc.edu
Phone: 412-647-7718
Fax: 412-648-6101
Education and Training
Education
PhD, Florida State University, 1990
Research Interest
Dr. Anderson’s Lab research interests include development of novel radiometal tracers for diagnostic imaging and targeted radiotherapy of cancer, pulmonary and cardiovascular diseases. Dr. Anderson pioneered the development of radiometal-labeled receptor-targeted PET imaging agents, leading the first human study of a 64Cu-labeled somatostatin analog in patients with neuroendocrine tumors. A current focus of her research lab is in the development of imaging agents for upregulated receptors on immune cells that are involved in inflammation related to lung diseases including tuberculosis, primary tumor growth and cancer metastasis. Another area of interest in is the development of targeted radionuclide therapy agents for prostate cancer and melanoma.
Clinical Interest
The Anderson Lab develops PET radiotracers for imaging of disease with the ultimate goal of translation into humans.
Educational Interest
Dr. Anderson has mentored many graduate students and postdocs who have gone on to successful careers in the field of molecular imaging. She has been a co-course master of NE2112 (Nuclear Chemistry and Radiochemistry) and has contributed lectures to BIOE 3505 (Molecular Imaging).
Publications
For my complete bibliography, Click Here.
Selected Publications:
Anderson CJ, Connett JM, Schwarz SW, Rocque PA, Philpott GW, Guo LW, Zinn KR, Meares CF, Welch MJ. Copper-64 labeled antibodies for PET imaging. Journal of Nuclear Medicine. 1992; 33: 1685-1691.
Sponsored Research/Activities
Title: G IRE1/XBP1s Signaling: A Novel essential regulator for bone marrow Microenviroment Support of Multiple Myeloma Bone
Role: Principal Investigator
Funding Agency: Texas A&M University/ National Cancer Institute
Start Year: 2019
End Year: 2019
Title: IRE1/XBP1s Signaling: A Novel essential regulator for bone marrow Microenviroment Support of Multiple Myeloma Bone
Role: Principal Investigator
Funding Agency: Texas A&M University
Grant Number: R01 CA182418
Start Year: 2018
End Year: 2019
Title: Development of a PSMA-Targeted Small-Molecule Drug Conjugate for Prostate Cancer
Role: Principal Investigator
Funding Agency: Cancer Targeted Technology, LLC
Grant Number: R43 CA221511
Start Year: 2018
End Year: 2019
Title: Image Guided Immunotherapy and Targeted Radionuclide Therapy of Metastatic Melanoma
Role: Principal Investigator
Funding Agency: National Cancer Institute
Grant Number: R01 CA214018
Start Year: 2017
End Year: 2021
Title: Therapeutic Efficacy of Lu-177-Labeled Albumin-Binding PSMA Analogs Compared to Lu-177-Labeled PSMA617
Role: Principal Investigator
Funding Agency: Cancer Targeted Technology, LLC
Grant Number: RES
Start Year: 2017
End Year: 2017
Title: PET Probes Targeting Immune Cells for Imaging Tuberculosis
Role: Co-Principal Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: R01 AI118195
Start Year: 2015
End Year: 2020
Title: PET Imaging of Vaso-Occlusion in Sickle Cell Disease: From Mice to Humans
Role: Co-Investigator
Funding Agency: Pittsburgh Foundation
Start Year: 2018
End Year: 2020
Title: Cancer Center Support Grant - InVivo Imaging Facility
Role: Core Leader
Funding Agency: National Cancer Institute
Grant Number: P30 CA047904
Start Year: 2016
End Year: 2019
Notable Achievements
SNMMI President's Award in Education, 2008
SNMMI Michael J Welch Award, 2012
Academy of Radiology Research Distinguished Investigator Award, 2014
Lawrence Berkeley Laboratory Patricia Durbin Memorial Lectureship, 2016